Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44Hi progenitors of taxol-resistant ovarian cancer cells

Oncology Reports

Volumn 23, Issue 6, 2010, Pages 1537-1543

  Mine, Takashi ^a,e   Matsueda, Satoko ^a   Gao, Hui ^a   Li, Yufeng ^a,b   Wong, Kwong Kwok ^a   Peoples, George E ^c   Ferrone, Soldano ^d   Ioannides, Constantin G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cell; Drug resistance; Gli 1; MicroRNA; Notch

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; JAGGED1; NOTCH RECEPTOR; PACLITAXEL; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GLI1; ANTINEOPLASTIC AGENT; CALCIUM BINDING PROTEIN; CD44 PROTEIN, HUMAN; GLI1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; SERRATE PROTEINS; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL DENSITY; CELL DIVISION; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; TUMOR CELL; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; GENETICS; METABOLISM; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIGENS, CD44; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; PACLITAXEL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 77951756987     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000793     Document Type: Article

References (29)

1. Orford KW and Scadden DT: Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 9: 115-128, 2008.
2. Klinakis A, Szabolcs M, Politi K, et al: Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA 103: 9262-9267, 2006. (Pubitemid 43902566)
3. Wong DJ, Liu H, Ridky TW, et al: Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2: 333-344, 2008. (Pubitemid 351455242)
4. Kruger JA, Kaplan CD, Luo Y, et al: Characterization of stem cell-like cancer cells in immune-competent mice. Blood 108: 3906-3912, 2006. (Pubitemid 44864575)
5. Boman BM, Wicha MS, Fields JZ, et al: Symmetric division of cancer stem cells-a key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin Pharmacol Ther 6: 893-898, 2007.
6. Lin H: Cell biology of the stem cells: An enigma of asymmetry and self-renewal. J Cell Biol 180: 257-260, 2008. (Pubitemid 351185911)
7. Noguera-Troise I, Daly C, Papadopoulos NJ, et al: Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444: 1032-1037, 2006. (Pubitemid 46018516)
8. Mizutani K, Yoon K, Dang L, et al: Differential Notch signalling distinguishes neural stem cells from intermediate progenitors. Nature 449: 351-355, 2007. (Pubitemid 47443472)
9. Hurlbut GD, Kankel MW, Lake RJ, et al: Crossing paths with Notch in the hyper-network. Current Opinion Cell Biol 19: 166-175, 2007.
10. Liu S, Dontu G, Mantle ID, et al: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071, 2006.
11. Di Marcotullio L, Ferretti E, Greco A, et al. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat Cell Biol 8: 1415-1423, 2006. (Pubitemid 44835117)
12. Hopfer O, Zwahlen D, Fey MF, et al: The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer 93: 709-718, 2005. (Pubitemid 41486463)
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al: Prospective identification tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
14. + CD24lo are eliminated by Numb-1 peptide-activated T cells. Cancer Immunol Immunother 58: 1185-1194, 2009.
15. Hoei-Hansen CE, Kraggerud SM, Abeler VM, et al: Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer 6: 12-23, 2007.
16. Zhang S, Balch C, Chan MW, et al: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320, 2008.
17. Kruger JA, Kaplan CD, Luo Y, et al: Characterization of stem cell-like cancer cells in immune-competent mice. Blood 108: 3906-3912, 2006.
18. Crawford TQ and Roelink H: The Notch response inhibitor DAPT enhances neuronal differentiation in embryonic stem cell-derived embryoid bodies independently of sonic hedgehog signaling. Dev Dyn 236: 886-892, 2007.
19. + cells to methylene groups appended to tumor antigen determines their differentiation or death. Cancer Res 65: 2930-2937, 2005.
20. Tsuda N, Ishiyama S, Li Y, et al: Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells. Clin Cancer Res 12: 6557-6564, 2006.
21. Castilleja A, Carter D, Efferson CL, et al: Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex. J Immunol 169: 3545-3554, 2002.
22. Tsuda N, Chang DZ, Mine T, et al: Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells. Cancer Res 67: 8378-8387, 2007.
23. Gordon WR, Vardar-Ulu D, Histen G, et al: Structural basis for autoinhibition of Notch. Nat Struct Mol Biol 14: 295-300, 2007.
24. Lehnhardt M, Klein-Hitpass L, Kuhnen C, et al: Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer 5: 74-89, 2005.
25. Sanchez P, Hernandez AM, Stecca B, et al: Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 101: 12561-12566, 2004.
26. Mani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008.
27. Bourguignon LY, Peyrollier K, Xia W, et al: Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 283: 17635-17651, 2008.
28. Liu S, Ginestier C, Charafe-Jauffret E, et al: BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 105: 1680-10685, 2008.
29. Liu ZJ, Xiao M, Balint K, et al: Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res 66: 4182-4190, 2006.